MENU
MAY 10, 2017 5:00 AM PDT

Complete workflow solution from gene-to-protein combine highly advanced expression systems with expression optimized genes

Speaker
  • Manager, Manufacturing , Thermo Fisher Scientific
    Biography
      Dr. Fath is a Manager, Manufacturing in the Biosciences Division at Thermo Fisher Scientific, GeneArt in Germany. Stephan received his PhD in protein biochemistry from the University of Heidelberg, Germany. After his education and research work on ribosomal biogenesis, he joined Memorial Sloan Kettering Cancer Center / New York, USA as a Research Fellow, studying COP II proteins by protein crystallography. Stephan has a strong background in protein biochemistry, expertise in different protein expression systems and a proven track record of publishing his scientific work in internationally renowned journals. In 2008 he joined GeneArt and worked as Senior Scientist in R&D before switching to Operations. As Manager, Manufacturing he is currently responsible for the highly customized protein expression & purification services.

    Abstract

    Reliable autologous expression of recombinant human proteins - from gene sequence to the expressed and purified protein - in human or CHO cells is essential for many aspects of biomedical research and drug development, but often hampered by low expression yields limiting subsequent structural and functional analyses.

    Thermo Fisher Scientific’s complete portfolio from Invitrogen™ GeneArt™ gene synthesis to advanced expression systems provides researchers the unique ability to optimize their gene expression results. Our proprietary sequence optimization GeneOptimizer™ algorithm improves the sequence via a parallel multi-parameter approach. To further maximize the protein yield, you can choose between our best-in-class serum free Gibco™ FreeStyle™ or Invitrogen™ Expi293™ and ExpiCHO™ expression host systems.

    This holistic approach is the most efficient way to streamline your gene-to-protein workflow for maximal performance, either by purchasing reagents for in-house work or by outsourcing the complete workflow as a highly customized service offered by the GeneArt™ Protein Team.

    The talk will explain the basis of gene synthesis and optimization and how the combination with the best expression system generates unmatched expression reliability and protein yields. This approach is highly advantageous early on during drug development to minimize changes in protein quality/function when moving from R&D to bioproduction.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    MAY 10, 2017 5:00 AM PDT

    Complete workflow solution from gene-to-protein combine highly advanced expression systems with expression optimized genes


    Specialty

    Cancer Research

    Biotechnology

    Cell Biology

    Molecular Biology

    Cell Culture

    Immunology

    Drug Discovery

    Antibodies

    Cancer Therapeutics

    Genetics

    Biomarkers

    Microbiology

    Crispr-Cas9

    Gene Expression

    Clinical Diagnostics

    Geography

    North America34%

    Europe27%

    Asia21%

    South America10%

    Africa8%

    Registration Source

    Website Visitors100%

    Job Title

    Student32%

    Research Scientist15%

    Post Doc10%

    Scientist9%

    Educator/Faculty7%

    Facility/Department Manager7%

    Executive6%

    Medical Laboratory Technician5%

    Marketing/Sales3%

    Clinical Laboratory Scientist2%

    Chemist2%

    Medical Doctor/Specialist1%

    Biologist1%

    Organization

    Biotech Company10%

    Academic Institution9%

    Research Institute6%

    Life Science Company5%

    Clinical Laboratory4%

    Government4%

    Medical School3%

    Hospital2%

    Veterinary School2%

    Ambulatory Care2%

    Media1%

    Manufacturer - Other1%

    Diagnostic Company1%

    Pharmaceutical Company1%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more